Kodiak Sciences KOD
NASDAQ KOD
$87.68 -5.29 (-5.69%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Convertible Debt (2017 - 2018)

Updated

Kodiak Sciences (KOD) posted Convertible Debt of $41.48 million for Q3 2018.

Analysis

Kodiak Sciences (KOD) Convertible Debt (2017 - 2018) Analysis & Trends

At the end of FY2017, Kodiak Sciences' Convertible Debt came in at $9.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kodiak Sciences 5.49 Bn 4.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 41.48 Mn
Dec 31, 2017 9.92 Mn
API Access

Kodiak Sciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=KOD&period=max&api_key=YOUR_API_KEY